OBJECTIVES

To create a pilot urologic malignancy registry using demographic and clinical data of a cohort of patients newly diagnosed to have urologic malignancies in the year 2021.

METHODS

This was a prospective cohort study conducted in four study sites: National Kidney and Transplant Institute, East Avenue Medical Center, UP-Philippine General Hospital and Batangas Medical Center

RESULTS

A total of 243 patients with newly diagnosed urologic cancers were enrolled. The median age was 61 years, with a wide range of 1 to 87 years. Most of the patients (81.47%) were male, while there were 45 females (18.52%) who had either urinary bladder, kidney or upper urothelial cancer. The most common type of malignancy was prostate cancer (34.57%), followed by kidney cancer (30.04%) and urinary bladder cancer (24.69%), consistent with the currently observed worldwide incidence. There were also 3 patients (1.23%) noted with multiple primaries. More than half of the patients (63.37%) received surgery as active treatment. After the two-year follow-up period, thirteen patients (5.35%) developed progressive disease, and 14 patients (5.76%) died.

CONCLUSION

This urologic cancer registry represents the first multi-center, investigator-initiated epidemiologic study of its kind in the Philippines. As a proof-of-concept (POC) project, it demonstrates the feasibility of establishing a national database capturing baseline data on the country’s most common urologic malignancies.

Cohort Studies ; Multiple Chronic Conditions ; Prostatic Neoplasms ; General Surgery ; Epidemiology

Objectives: To identify practice variations among adult urologists in the surgical management of their oncologic cases and postoperative complications. Methods: Beginning March 2022 to October 2022 an internet-based survey was performed among members of the PUA practicing in the Philippines. Results: 82 Philippine urologists answered the survey during the study period. Majority have no subspecialty training (n=42) and practice primarily in the NCR (n=49). Open radical prostatectomy is the option of choice (n=58) with reported incidence of complications similar to that of previous studies. Conduit (n=77) is the diversion of choice after radical cystectomy with the majority recommending a two-surgeon approach in the harvest and reconstruction. Conclusion Practice is focused within the NCR with the majority having no subspecialty training thus preferring open surgical approach and two-surgeon team. Implantable devices are the preferred method in managing erectile dysfunction and urinary incontinence but is still lacking local availability.

INTRODUCTION AND OBJECTIVES: Laparoscopic adrenalectomy is the standard treatment for adrenal tumors.Described here is the authors’ 10-year experience with laparoscopic adrenalectomy in a single center. METHODS: A retrospective chart review was done on all patients who underwent laparoscopicadrenalectomy from January 2006 to January 2016 at the National Kidney and Transplant Institute.The authors determined the patient demographics (age and gender), tumor characteristics (size,functionality and laterality) and surgical outcomes (operative time, estimated blood loss, conversionto open and complications according to the Clavien-Dindo classification). RESULTS: A total of 90 patients underwent laparoscopic adrenalectomy. The female to male ratio was1.4:1. Most tumors were left-sided [48/90 (53%)], with a mean size of 3.0 ± 0.75cm. The operativetime was 145 ± 35 minutes. The mean estimated blood loss was 50 ± 100cc. The length of hospitalstay was 3.0 ± 1 days. Forty six percent (42/90) of the adrenals were functioning: Hyperaldosteronism(26), Pheochromocytoma (14), and Cushing's syndrome (2). Ninety eight percent(88/90) were benign. There were 2 (2.2%) conversions to open. There were 8 complications (8.89%)(all Dindo-Clavien Class II), all of which were managed conservatively. There was no mortality. CONCLUSION The authors’ experience with laparoscopic adrenalectomy shows that it is safe and effectivefor adrenal tumors.
Laparoscopy